Genmab (GMAB)

Copenhagen


Symbol		Exchange		Currency
GMAB	·	Copenhagen	·	DKK	Real-time
GMABc	·	BATS Europe	·	DKK	Delayed
GMAB	·	NASDAQ	·	USD	Real-time
0MGB	·	London	·	DKK	Real-time
GE91y	·	TradeGate	·	EUR	Delayed
GMAB	·	Vienna	·	EUR	Real-time

Currency in DKK

GMAB Pro Research

1,690.0

+35.0(+2.11%)

Closed·30/04

Fair Value

Unlock Value

Day's Range

1,652.0

1,704.0

52 wk Range

1,204.5

2,257.0

GMAB Income Statement

Featured here, the Income Statement (earnings report) for Genmab, showing the company's financial performance from operating and non operating activities such as revenue, expenses and income for the last 4 periods (either quarterly or annually).

Period Ending:

2016

31/12

2017

31/12

2018

31/12

2019

31/12

2020

31/12

2021

31/12

2022

31/12

2024

01/01

2024

31/12

2025

31/12

Total Revenues

aa.aa

1,286.96

2,087.27

2,390

3,121

3,720

Total Revenues Growth

aa.aa

-22.44%

+62.19%

+14.5%

+30.59%

+19.19%

Cost Of Revenues

aa.aa

143

238

Gross Profit

aa.aa

1,286.96

2,087.27

2,357

2,978

3,482

Gross Profit Growth

aa.aa

-22.44%

+62.19%

+12.92%

+26.35%

+16.92%

Gross Profit Margin %

aa.aa

100%

98.62%

95.42%

93.6%

Other Operating Expenses, Total

aa.aa

835.45

1,185.45

1,585

1,963

2,232

	Other Operating Expenses, Total Growth
	R&D Expenses
	Selling General & Admin Expenses
	Other Operating Expenses

aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	+34.05%	+41.89%	+33.7%	+23.85%	+13.7%
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	639.27	800.37	1,107	1,414	1,606
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	196.17	385.08	478	549	626
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-	-	-	-	-

Operating Income

aa.aa

451.51

901.82

772

1,015

1,250

Operating Income Growth

aa.aa

-56.42%

+99.73%

-14.4%

+31.48%

+23.15%

EBIT Margin %

aa.aa

35.08%

43.21%

32.3%

32.52%

33.6%

Net Interest Expenses

aa.aa

28.13

41.01

132

126

Net Interest Expenses Growth

aa.aa

-1.47%

+45.77%

+221.86%

-4.55%

-38.89%

Interest Expense, Total

aa.aa

-1.99

-5.61

-10

-18

-61

Interest And Investment Income

aa.aa

30.12

46.62

142

144

138

Other Non Operating Expenses, Total

aa.aa

224.76

151.24

-66

-3

EBT, Excl. Unusual Items

aa.aa

704.41

1,094.07

838

1,233

1,324

Gain (Loss) On Sale Of Assets

aa.aa

Other Unusual Items, Total

aa.aa

EBT, Incl. Unusual Items

aa.aa

599.06

999.39

817

1,326

1,204

EBT, Incl. Unusual Items Growth

aa.aa

-38.17%

+66.82%

-18.25%

+62.3%

-9.2%

EBT, Incl. Unusual Items Margin

aa.aa

46.55%

47.88%

34.18%

42.49%

32.37%

Income Tax Expense

aa.aa

146.94

214.84

186

193

241

Net Income to Company

aa.aa

452.13

784.54

631

1,133

963

Minority Interest

aa.aa

Net Income

aa.aa

452.13

784.54

631

1,133

963

Net Income Growth

aa.aa

-42.09%

+73.52%

-19.57%

+79.56%

-15%

Net Income Margin %

aa.aa

35.13%

37.59%

26.4%

36.3%

25.89%

Preferred Dividend and Other Adjustments

aa.aa

Net Income to Common Excl. Extra Items

aa.aa

452.13

784.54

631

1,133

963

Basic EPS - Continuing Operations

aa.aa

6.91

9.66

17.65

15.49

Basic EPS - Continuing Operations Growth

aa.aa

-42.29%

+73.55%

-19.48%

+82.7%

-12.22%

Diluted EPS - Continuing Operations

aa.aa

6.85

11.88

9.58

17.53

15.37

Diluted EPS - Continuing Operations Growth

aa.aa

-42.23%

+73.62%

-19.39%

+82.99%

-12.32%

Basic Weighted Average Shares Outstanding

aa.aa

9.41

65.31

64.19

62.15

Diluted Weighted Average Shares Outstanding

aa.aa

10.1

9.5

65.9

64.66

62.69

Dividend Per Share

aa.aa

Dividend Per Share Growth

aa.aa

EBITDA

aa.aa

481.18

943.26

802

1,052

1,290

EBITDA Growth

aa.aa

-55.19%

+96.03%

-14.98%

+31.17%

+22.62%

EBITDA Margin %

aa.aa

37.39%

45.19%

33.56%

33.71%

34.68%

EBIT

aa.aa

451.51

901.82

772

1,015

1,250

* In Millions of USD (except for per share items)

FAQ

What was Genmab’s revenue at year end?

At the end of the last reported fiscal year, Genmab (GMAB) recorded total revenue of 3,720.0 million USD.

How much revenue did Genmab report in the most recent quarter?

In its most recent quarterly earnings report, Genmab posted revenue of 6,728.0 million USD.

What was Genmab’s net income for the year?

For the full year, Genmab reported net income of 963.0 million USD.

How much net income did Genmab post in the last quarter?

In the most recent quarter, Genmab (GMAB) posted net income of 197.1 million USD.

What was Genmab’s gross profit for the year?

Gross profit for the year was reported at 3,482.0 million USD.

How much gross profit did Genmab generate last quarter?

Genmab recorded gross profit of 6,212.9 million USD in its latest quarterly report.

What was Genmab’s annual operating income?

For the full year, Genmab (GMAB) reported operating income of 1,250.0 million USD.

What was Genmab’s operating income last quarter?

Quarterly operating income was 1,545.3 million USD.

What was Genmab’s quarterly EBITDA?

In the latest quarter, EBITDA was reported at 1,558.0 million USD.

What was the quarter-over-quarter change in EBITDA for Genmab?

EBITDA changed by -48.2% million USD compared to the last quarter.

What is Genmab’s most recent gross profit margin?

The latest reported gross profit margin for Genmab (GMAB) is 92.3% million USD.

What is Genmab’s most recent net income margin?

Net income margin based on recent financials is 2.9% million USD.

What is Genmab’s most recent EBIT margin?

Genmab reported an EBIT margin of 23.0% million USD based on current figures.

How did Genmab’s revenue change compared to the previous quarter?

Revenue changed by 3.5% million USD compared to the prior quarter.

What was the quarter-over-quarter change in gross profit for Genmab?

In the latest quarter, gross profit changed by 1.3% million USD from the previous quarter.

PSEi Composite

5,833.64

-74.25

-1.26%

Nikkei 225

59,592.50

+307.58

+0.52%

Shanghai

4,112.16

+4.64

+0.11%

US 500

7,230.90

+21.9

+0.30%

US Tech 100

27,508.80

+56.7

+0.21%

DAX

24,292.38

+337.82

+1.41%

Dollar Index

98.017

+0.057

+0.06%

Market Movers

Name	Last	Chg. %	Vol.
Ayala Land	15.100	-4.19%	19.92M
BDO Unibank	114.20	-1.38%	9.98M
Bank of the Philippine Islands	89.50	-2.51%	5.64M
International Container	710.000	-1.39%	1.98M
GT Capital	473.00	-1.25%	469.15K
SM Investments	606.00	-2.26%	446.25K
Ayala	467.60	-2.38%	422.49K

Name	Last	Chg. %	Vol.
Roxas	2.730	+21.87%	720.00K
Max’s Group	2.650	+16.23%	149.00K
Prime Media	0.830	+15.28%	2.00K
Cirtek Holdings Philippines Prf	9.15	+9.45%	3.50K
Manulife Financial	2,300.00	+8.49%	25.00
Wellex Industries	0.320	+8.47%	10.00K
Oriental Petrol	0.0130	+8.33%	1.30M

Name	Last	Chg. %	Vol.
Medilines Distributors	0.22	-12.24%	420.00K
ABS-CBN Holdings	2.50	-7.06%	58.00K
Primex	1.100	-5.98%	22.00K
Now	0.540	-5.26%	1.27M
Boulevard	0.0380	-5.00%	65.30M
Semirara Mining	26.00	-4.94%	3.53M
Liberty Flour Mills	33.000	-4.76%	300.00

Trending Stocks

Name	Last	Chg. %	Vol.
Ayala Land	15.100	-4.19%	19.92M
Bank of the Philippine Islands	89.50	-2.51%	5.64M
Manila Electric	652.00	-1.51%	280.24K
Dito CME Holdings	1.0000	0.00%	97.18M
BDO Unibank	114.20	-1.38%	9.98M

Most Undervalued Stocks

Name	Last	Upside	Fair Value
Aaaaaaaaaaa	3.580	+47.96%	5.297
Aa Aaaa Aaaa	2.080	+45.85%	3.034
Aa A Aaa Aa Aaaaaa	2.090	+45.75%	3.046
Aa Aaaa Aaaa Aaaaaaa	29.100	+42.92%	41.590
A Aaaaaa Aaaaaaa	52.40	+40.14%	73.43
Aaaaaaaaaa	2.940	+39.51%	4.102
Aaa Aaaa Aaa	1.860	+38.45%	2.575

Name	Last	Upside	Fair Value
Aaaaaaaaaaa	3.580	+47.96%	5.297
Aa Aaaa Aaaa	2.080	+45.85%	3.034
Aa A Aaa Aa Aaaaaa	2.090	+45.75%	3.046
Aa Aaaa Aaaa Aaaaaaa	29.100	+42.92%	41.590
A Aaaaaa Aaaaaaa	52.40	+40.14%	73.43
Aaaaaaaaaa	2.940	+39.51%	4.102
Aaa Aaaa Aaa	1.860	+38.45%	2.575

See full list

Install Our AppScan QR code to install app

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

Popular Searches

Please try another search

Genmab (GMAB)

GMAB Income Statement

FAQ

What was Genmab’s revenue at year end?

How much revenue did Genmab report in the most recent quarter?

What was Genmab’s net income for the year?

How much net income did Genmab post in the last quarter?

What was Genmab’s gross profit for the year?

How much gross profit did Genmab generate last quarter?

What was Genmab’s annual operating income?

What was Genmab’s operating income last quarter?

What was Genmab’s quarterly EBITDA?

What was the quarter-over-quarter change in EBITDA for Genmab?

What is Genmab’s most recent gross profit margin?

What is Genmab’s most recent net income margin?

What is Genmab’s most recent EBIT margin?

How did Genmab’s revenue change compared to the previous quarter?

What was the quarter-over-quarter change in gross profit for Genmab?

Trending Stocks